Neuropsychiatric presentation of Niemann-Pick type C disease: case report and literature review

Main Article Content

Bruno Previdelli Coghi
Beatriz Bettiol Nicoletti
Bruna Sandy Pastre
Bruna Isepão Barboza da-Silva
Zumira Aparecida Carneiro
Jacqueline Fonseca
Regina Albuquerque
Laura Vagnini
Marcela Almeida
Debora de Cassia Tomaz
Fernanda Veiga Goes
Tainá Regina Damaceno Silveira
Ana Paula Andrade Hamad
Fernanda Timm
Charles Marques Lourenco

Abstract

Introduction: Niemann-Pick type C (NP-C) is an inherited autosomal
recessive genetic disease, caused by mutations in the NPC1 and
NPC2 gene, causing neurovisceral lysosomal storage. Lysosomal
storage is consequence of cellular traffic defect that leads to glycos
phingolipid and cholesterol accumulation in many organs, progres
sing to premature cell death. This disease has a prevalence of 1:
120,000, in which about 95% of patients with the syndrome exhibit
alterations in the NPC1 gene and only 5% have mutations in NPC2
gene. Patients with NP-C disease may present several phenotypes,
from the neonatal-infantile form with visceral manifestations such
as organomegaly and cholestasis, to the juvenile-adult form, with
progressive neurological degeneration. Case report: 18-year-old fe
male patient referred for investigation of neuropsychiatric disorder
(“schizophrenia-like” and vertical supranuclear gaze palsy), associa
ted with motor manifestations (ataxia, mild dystonia and dysarthria).
According to the clinical findings and physical examination, Filipin
test and genetic sequencing were requested, confirming NP-C.
After diagnosis, patient was started on substrate reduction therapy
(TRS) with Miglustat, showing clinical stabilization. Discussion: NP-C
should be considered as a differential diagnosis of several diseases with
progressive visceral and neuropsychiatric manifestations, in order to direct
its investigation. Since NP-C is potentially treatable and given its progressive
character, early diagnosis becomes essential, not only for better clinical
prognosis of the patient, but also to allow family genetic counseling.

Downloads

Download data is not yet available.
👁 Abstract Views: 120📥 PDF PT (Português (Brasil)) Downloads: 4

Article Details

How to Cite
Bruno Previdelli Coghi, Beatriz Bettiol Nicoletti, Bruna Sandy Pastre, Bruna Isepão Barboza da-Silva, Zumira Aparecida Carneiro, Jacqueline Fonseca, … Charles Marques Lourenco. (2021). Neuropsychiatric presentation of Niemann-Pick type C disease: case report and literature review. Revista De Pediatria SOPERJ, 22(1), 41–46. https://doi.org/10.31365/issn.2595-1769.v22i1p41-46
Section
Relato de Caso

References

1 Dougherty M, Lazar J, Klein JC, Diaz K, Gobillot T, Grunblatt E. et al. Genome sequencing in a case of Niemann-Pick type C. Mol Case Stud 2016; 2: a001222.

2 Amaral I do SA, Moia L de JMP, Coelho EFA, Medeiros ZL de, Montoril M de FP, Araujo MTF. Relatório de caso: doença de Niemann-Pick com manifestações de insuficiência hepática. Rev Pan-Amaz Saúde 2010; 1. doi:10.5123/S2176-62232010000300017.

3 Niemann-Pick C Disease Gene Mutations and Age-Related Neurodegenerative Disorders. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0082879 (accessed 21 May2019).

4 Kheder A, Scott C, Olpin S, Hadjivassiliou M. Niemann-Pick type C: a potentially treatable disorder? Pract Neurol 2013; 13: 382-385.

5 Koens LH, Kuiper A, Coenen MA, Elting JWJ, de Vries JJ, Engelen M et al. Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C. Orphanet J Rare Dis 2016; 11: 121.

6 Piroth T, Boelmans K, Amtage F, Rijntjes M, Wierciochin A, Musacchio T et al. Adult-Onset Niemann-Pick Disease Type C: Rapid Treatment Initiation Advised but Early Diagnosis Remains Difficult. Front Neurol 2017; 8. doi:10.3389/fneur.2017.00108.

7 Nevsimalova S, Malinova V. Cataplexy and Sleep Disorders in Niemann-Pick Type C Disease. Curr Neurol Neurosci Rep 2014; 15: 522.

8 Evans WRH, Hendriksz CJ. Niemann-Pick type C disease - the tip of the iceberg? A review of neuropsychiatric presentation, diagnosis and treatment. BJPsych Bull 2017; 41: 109-114.

9 Patterson MC, Clayton P, Gissen P, Anheim M, Bauer P, Bonnot O et al. Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An update. Neurol Clin Pract 2017; : 1.

10 Lorenzoni PJ, Cardoso E, Crippa ACS, Lourenço CM, Souza FTS, Giugliani R et al.http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0004-282X2014000300214&lng=en&nrm=iso&tlng=es. Arq Neuropsiquiatr 2014; 72: 214-218.

11 Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT et al. The adult form of Niemann-Pick disease type C. Brain 2006; 130: 120-133.

12 Imrie J, Heptinstall L, Knight S, Strong K. Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database. BMC Neurol 2015; 15: 257.

13 Schicks J, Muller Vom Hagen J, Bauer P, Beck-Wodl S, Biskup S, KrägelohMann I, et al. Niemann-Pick type C is frequent in adult ataxia with cognitive decline and vertical gaze palsy. Neurology. 2013; 80:1169-70.

14 Bauer P, Balding DJ, Klunemann HH, Linden DEJ, Ory DS, Pineda M et al. Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study. Human Molecular Genetics 2013; 22: 4349-4356.

15 Maubert A, Hanon C, Sedel F. Psychiatric disorders in adult form of Niemann-Pick disease type C. L'Encephale. 2016; 42:208-13.

16 Bergeron D, Poulin S, Laforce R Jr. Cognition and anatomy of adult Niemann-Pick disease type C: insights for the Alzheimer field. Cogn Neuropsychol. 2017; 35:1-14.

17 Nadjar Y, Hütter-Moncada AL, Latour P, Ayrignac X, Kaphan E, Tranchant C et al. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect. Orphanet J Rare Dis 2018; 13: 175.

18 Stein VM, Crooks A, Ding W, Prociuk M, O'Donnell P, Bryan C et al. Miglustat Improves Purkinje Cell Survival and Alters Microglial Phenotype in Feline Niemann-Pick Disease Type C. J Neuropathol Exp Neurol 2012; 71: 434-448.

19 Wraith JE, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C et al. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: Long-term data from a clinical trial. Molecular Genetics and Metabolism 2010; 99: 351-357.

20 Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, et al. Miglustat in patients with Niemann-pick disease type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab 2009; 98:243-9.

21 Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. The Lancet Neurology 2007; 6: 765-772.

22 Actelion. Miglustat (Zavesca) Summary of Product Characteristics, EMA. (EudraPharm) 2010. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000435/human_med_001171.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b0 1ac058001d125. Accessed 31 Aug 2018.

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

You may also start an advanced similarity search for this article.